Amarin (AMRN) Shakes Off Weakness, Sees Notable Upside
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/11/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Wall Street ends higher as investors turn to earnings season
- AppLovin gains market share among e-commerce advertisers
Jefferies Maintains a 'Buy' on Amarin (AMRN); Concern Over NCE Delay And Meta-analysis Presents A Buying Opportunity
September 12, 2012 7:08 AM EDTJefferies maintains a 'Buy' on Amarin Corporation (NASDAQ: AMRN) price target of $28.00.
Analyst, Thomas Wei, said, "We believe investor speculation over further delays in Vascepas New Chemical Entity (NCE) decision, plus a minor concern for a new meta-analysis, has contributed to stock... More
Amarin (AMRN) NCE Delay Could Be Related to Patents
September 11, 2012 10:37 AM EDTMKM Partners commented on Amarin Corporation (NASDAQ: AMRN) Tuesday following another NCE decision delay on Vascepa.
Analyst Jon LeCroy, M.D. said he continues to believe the delay is a mild... More
Amarin Corp (AMRN) Pressured Early as Vascepa Orange Book Decision Delayed...Again
September 11, 2012 8:15 AM EDTShares of Amarin Corp Plc (Nasdaq: AMRN) are getting hit Tuesday morning following a late-Monday disclosure for Vascepa.
According to the filing, Amarin... More
Amarin (AMRN) Said No FDA NCE Decision in August Orange Book
September 10, 2012 5:10 PM EDTAmarin Corp Plc (NASDAQ: AMRN) said after the close of trading Monday that it does not expect an FDA NCE decision by the next Orange Book, due on our about September 14, 2012.
From the filing:
Typically, the U.S. Food and Drug Administration (FDA) publishes a determination on the... More
